Bio-signal Telemonitoring Using Electronic Textiles in a Pediatric Population
1 other identifier
interventional
20
1 country
1
Brief Summary
There is a need for developing reliable and convenient technologies for telemonitoring of physiological signals such as respiration, cardiac function, and activity level in children and especially for those with heart disease. Changing symptomatology causes heart failure patients to seek medical attention in order to be assessed and potentially have medication adjusted or additional testing being undertaken. These frequent clinical encounters affect the quality of life of these children and their parents, as well as being costly for the health care system. A textile based technology for telemonitoring application that is comfortable and accurate in its data collection can help to provide real time information on physiologic parameters. The primary research objective is to determine the feasibility and validity of a textile-enabled sensor system in measuring physiologic variables, or "biological signals", related to cardiopulmonary function in children. The study will include 10 patients with heart failure, and 10 healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable heart-failure
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2019
CompletedFirst Posted
Study publicly available on registry
March 12, 2020
CompletedStudy Start
First participant enrolled
September 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedJuly 7, 2023
July 1, 2023
7 months
November 29, 2019
July 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Validate the heart rate measurements obtained using the SKIIN Textile in children with and without heart disease.
Validate the heart rate measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Grael 4K PSG
40 minutes
Validate the respiratory rate measurements obtained using the SKIIN Textile in children with and without heart disease.
Validate the respiratory rate measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Grael 4K PSG.
40 minutes
Validate the pulse oximetry measurements obtained using the SKIIN Textile in children with and without heart disease.
Validate the pulse oximetry measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Nonin, WristOx2TM, Model 3150, Wrist-worn Pulse Oximeter
40 minutes
Secondary Outcomes (1)
To extract and analyze temperature data obtained using the SKIIN Textile in children with
40 minutes
Study Arms (2)
SKIIN Textile Device in children with healthy hearts
EXPERIMENTALThe Myant SKIIN Device will be worn by study participants while they lay down, sit, stand, exercise and cool-down.
SKIIN Textile Device in children with heart failure
EXPERIMENTALThe Myant SKIIN Device will be worn by study participants while they lay down, sit, stand, exercise and cool-down
Interventions
1. Supine position: Participant lays on a bed on their back for 5 minutes 2. Sitting position: Participant sits on a chair for 5 minutes 3. Standing position: Participant stands for 5 minutes. 4. Exercise measurement: treadmill exercise test - the protocol entails increases of 0.5 mph every minute with zero change in the incline. Starting point would 1.5 mph. The test will be interrupted if the target heart rate of 190 beats per minute is reached or if symptoms and/or arrhythmias and ST depression would be observed. Patient will be monitor during recovery for 5 minutes. 5. Cool-down: Participants cool-down for 5 minutes
Eligibility Criteria
You may qualify if:
- Healthy children participants (i.e. without CHD or HF) aged between 10 to 18 years with normal electrocardiograms and normal echocardiograms (i.e. screens for familial cardiomyopathy).
- Patients aged between 10 and 18 years with diagnosed congenital heart disease or cardiomyopathies referred to pediatric cardiology ambulatory clinic at SickKids.
You may not qualify if:
- In-hospital patients.
- Patients too ill to participate or perform any activity.
- Patients with Fontan/single ventricle physiology circulation.
- Children who are less than 6 months post op from a cardiac surgery as they will have concerns from an activity and wound care standpoint.
- Participants with known allergies to adhesives (as reported by family).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aamir Jeewalead
- Toronto Rehabilitation Institutecollaborator
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5G1X8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aamir Jeewa, MD
The Hospital for Sick Children
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Staff Cardiologist
Study Record Dates
First Submitted
November 29, 2019
First Posted
March 12, 2020
Study Start
September 15, 2021
Primary Completion
April 1, 2022
Study Completion
March 30, 2023
Last Updated
July 7, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share